STING1 and neoplasm: Tumour cell death was accompanied by the release of IFN-β, TNF-α, and IL-6 (attributed to cGAS/STING activation in the surrounding immune milieu following immunogenic cell death), all of which are drivers of anti-tumour inflammation.